Terms: = Skin cancer AND FGFR2, BFR-1, 2263, ENSG00000066468, TK14, BEK, CD332, JWS, TK25, ECT1, CEK3, K-SAM, CFD1, KGFR AND Treatment
16 results:
1. A drug safety evaluation of pemigatinib for advanced cholangiocarcinoma.
Uson PLS; Bearss J; Babiker HM; Borad M
Expert Opin Drug Saf; 2023; 22(8):637-641. PubMed ID: 37363820
[TBL] [Abstract] [Full Text] [Related]
2. FDA Approval Summary: Pemigatinib for Previously Treated, Unresectable Locally Advanced or Metastatic Cholangiocarcinoma with fgfr2 Fusion or Other Rearrangement.
Patel TH; Marcus L; Horiba MN; Donoghue M; Chatterjee S; Mishra-Kalyani PS; Schuck RN; Li Y; Zhang X; Fourie Zirkelbach J; Charlab R; Liu J; Yang Y; Lemery SJ; Pazdur R; Theoret MR; Fashoyin-Aje LA
Clin Cancer Res; 2023 Mar; 29(5):838-842. PubMed ID: 36206041
[TBL] [Abstract] [Full Text] [Related]
3. Bilateral parotid glands aplasia: a case report and literature review.
Kuralt H; Fidler A; Blatnik A; Novaković S; Plavc G
Oral Radiol; 2022 Jul; 38(3):423-429. PubMed ID: 35076829
[TBL] [Abstract] [Full Text] [Related]
4. TBCRC 032 IB/II Multicenter Study: Molecular Insights to AR Antagonist and PI3K Inhibitor Efficacy in Patients with AR
Lehmann BD; Abramson VG; Sanders ME; Mayer EL; Haddad TC; Nanda R; Van Poznak C; Storniolo AM; Nangia JR; Gonzalez-Ericsson PI; Sanchez V; Johnson KN; Abramson RG; Chen SC; Shyr Y; Arteaga CL; Wolff AC; Pietenpol JA;
Clin Cancer Res; 2020 May; 26(9):2111-2123. PubMed ID: 31822498
[TBL] [Abstract] [Full Text] [Related]
5. Fibroblast growth factor receptor promotes progression of cutaneous squamous cell carcinoma.
Khandelwal AR; Kent B; Hillary S; Alam MM; Ma X; Gu X; DiGiovanni J; Nathan CO
Mol Carcinog; 2019 Oct; 58(10):1715-1725. PubMed ID: 31254372
[TBL] [Abstract] [Full Text] [Related]
6. Gene expression profiling in aggressive digital papillary adenocarcinoma sheds light on the architecture of a rare sweat gland carcinoma.
Surowy HM; Giesen AK; Otte J; Büttner R; Falkenstein D; Friedl H; Meier F; Petzsch P; Wachtmeister T; Westphal D; Wieczorek D; Wruck W; Adjaye J; Rütten A; Redler S
Br J Dermatol; 2019 May; 180(5):1150-1160. PubMed ID: 30472730
[TBL] [Abstract] [Full Text] [Related]
7. Analysis of clinically relevant somatic mutations in high-risk head and neck cutaneous squamous cell carcinoma.
Zilberg C; Lee MW; Yu B; Ashford B; Kraitsek S; Ranson M; Shannon K; Cowley M; Iyer NG; Palme CE; Ch'ng S; Low TH; O'Toole S; Clark JR; Gupta R
Mod Pathol; 2018 Feb; 31(2):275-287. PubMed ID: 28984303
[TBL] [Abstract] [Full Text] [Related]
8. UV-Associated Mutations Underlie the Etiology of MCV-Negative Merkel Cell Carcinomas.
Wong SQ; Waldeck K; Vergara IA; Schröder J; Madore J; Wilmott JS; Colebatch AJ; De Paoli-Iseppi R; Li J; Lupat R; Semple T; Arnau GM; Fellowes A; Leonard JH; Hruby G; Mann GJ; Thompson JF; Cullinane C; Johnston M; Shackleton M; Sandhu S; Bowtell DD; Johnstone RW; Fox SB; McArthur GA; Papenfuss AT; Scolyer RA; Gill AJ; Hicks RJ; Tothill RW
Cancer Res; 2015 Dec; 75(24):5228-34. PubMed ID: 26627015
[TBL] [Abstract] [Full Text] [Related]
9. Resistance surveillance in a BRAF mutant melanoma patient on long-term BRAF-inhibitor treatment.
Mak G; Arkenau HT; Chin M
Melanoma Res; 2014 Aug; 24(4):408-12. PubMed ID: 24858661
[TBL] [Abstract] [Full Text] [Related]
10. fgfr2 signaling underlies p63 oncogenic function in squamous cell carcinoma.
Ramsey MR; Wilson C; Ory B; Rothenberg SM; Faquin W; Mills AA; Ellisen LW
J Clin Invest; 2013 Aug; 123(8):3525-38. PubMed ID: 23867503
[TBL] [Abstract] [Full Text] [Related]
11. Spared pre-irradiated area in pustular lesions induced by icotinib showing decreased expressions of CD1a+ langerhans cells and fgfr2.
Zhao Q; Wang YN; Wang B
Jpn J Clin Oncol; 2013 Feb; 43(2):200-4. PubMed ID: 23264674
[TBL] [Abstract] [Full Text] [Related]
12. Keratinocyte growth factor induces gene expression signature associated with suppression of malignant phenotype of cutaneous squamous carcinoma cells.
Toriseva M; Ala-aho R; Peltonen S; Peltonen J; Grénman R; Kähäri VM
PLoS One; 2012; 7(3):e33041. PubMed ID: 22427941
[TBL] [Abstract] [Full Text] [Related]
13. Somatic cell plasticity and Niemann-pick type C2 protein: adipocyte differentiation and function.
Csepeggi C; Jiang M; Frolov A
J Biol Chem; 2010 Sep; 285(39):30347-54. PubMed ID: 20650896
[TBL] [Abstract] [Full Text] [Related]
14. Altered expression of keratinocyte growth factor and its receptor in psoriasis.
Finch PW; Murphy F; Cardinale I; Krueger JG
Am J Pathol; 1997 Dec; 151(6):1619-28. PubMed ID: 9403712
[TBL] [Abstract] [Full Text] [Related]
15. Keratinocyte growth factor receptor ligands induce transforming growth factor alpha expression and activate the epidermal growth factor receptor signaling pathway in cultured epidermal keratinocytes.
Dlugosz AA; Cheng C; Denning MF; Dempsey PJ; Coffey RJ; Yuspa SH
Cell Growth Differ; 1994 Dec; 5(12):1283-92. PubMed ID: 7535082
[TBL] [Abstract] [Full Text] [Related]
16. Keratinocyte growth factor induces proliferation of hepatocytes and epithelial cells throughout the rat gastrointestinal tract.
Housley RM; Morris CF; Boyle W; Ring B; Biltz R; Tarpley JE; Aukerman SL; Devine PL; Whitehead RH; Pierce GF
J Clin Invest; 1994 Nov; 94(5):1764-77. PubMed ID: 7962522
[TBL] [Abstract] [Full Text] [Related]
